Acadia Healthcare Company, Inc. (ACHC) fair value analysis
Nasdaq · Updated 2026-10-19
ACHC price how computed
Forward Fair Value verdict
Fairly valuedACHC is trading at within about 10% of estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $29.98
- Sector
- Healthcare
- 12-month range
- $11.68–$35.61
- Market cap
- $2.79B
- From 52-week high
- -15.8%
- Shares outstanding
- 93.1M
- Rank in Healthcare by discount to fair value
- #105 of 108
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
Acadia Healthcare Company, Inc. operates a network of behavioral health and specialty hospitals across the United States and internationally. The company provides inpatient and outpatient treatment services for patients with psychiatric, substance abuse, and other behavioral health conditions.
ACHC currently ranks #105 of 108 Healthcare stocks by discount to fair value. It has screened as Fairly valued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $2.79B
- P/E (trailing)
- 19x
- Revenue (TTM)
- $3.37B
- Net margin
- -33.4%
- EPS (TTM)
- $1.54
- Gross margin
- 16.6%
- Debt / equity
- 1.30
- Revenue growth (3-yr avg)
- 5.1%
- Shares outstanding
- 93.1M
Derived indicators how computed
- Quality grade
- F
- Margin trend
- Contracting
- 52-week position
- The top quarter of its range
Technicals how computed
- RSI (14-day)
- 54 · neutral
- 50-day average
- $28.93
- 200-day average
- $24.94
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Earnings how computed
- Next earnings report
- 2026-11-04 (post-market)
- Last 8 quarters vs consensus
- 6 beat, 2 missed
- Quarter by quarter
- 2026-06 ▲ beat (+15.2%)
2026-03 ▲ beat (+42.3%)
2025-12 ▼ miss (-30.0%)
2025-09 ▲ beat (+7.5%)
2025-06 ▲ beat (+16.9%)
2025-03 ▲ beat (+11.1%)
2024-12 ▼ miss (-10.4%)
2024-09 ▲ beat (+1.1%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 8 buy · 5 hold · 1 sell (14 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $33.8
- Target vs last price
- +12.7%
What our data shows for ACHC
- Our model validated 17 trailing price-to-earnings windows for ACHC, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $11.68–$35.61.
- The 14-day relative strength index sits at a neutral 54.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for ACHC
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent ACHC news
TickrTrends' derived news-sentiment signal for ACHC is currently leaning positive, computed from recent coverage.
- DIMENSIONAL FUND ADVISORS LP Boosts Acadia Healthcare Co Inc (ACHC) Stake -- Shares Look 24% Undervalued on GF Value (gurufocus.com, 2026-10-15)
TickrTrends take: Dimensional Fund Advisors LP recently increased its position in Acadia Healthcare, a move that contrasts with TickrTrends' assessment that the stock is fairly valued. The discrepancy between the fund's buying activity and the fairly valued rating suggests investors may want to monitor whether the company's fundamentals shift in coming quarters to clarify which valuation view proves more accurate. For those focused on valuation metrics, tracking changes in the company's financial performance and how the market reprices ACHC relative to peers in the Healthcare sector will be important. - Acadia Healthcare Company, Inc. at Jefferies Healthcare Services and Technology Conference Transcript (gurufocus.com, 2026-09-15)
TickrTrends take: Acadia Healthcare Company, Inc. operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends analysis. For investors focused on valuation, the company's appearance at the Jefferies Healthcare Services and Technology Conference provides an opportunity to evaluate management commentary against the current fair value assessment. Monitoring how the company's strategic positioning and operational updates align with market expectations will be relevant for tracking whether the fairly valued designation remains appropriate.
What people are saying
Follow the ACHC conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — ACHC moved into an uptrend based on its 50/200-day moving average relationship this week, shifting from a mixed trend state. The stock's sector discount rank declined to #70 from #61, meaning it trades at a smaller discount to other healthcare companies. At its current valuation, ACHC is assessed as fairly valued.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is ACHC stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), ACHC is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is ACHC's TickrTrends verdict?
ACHC's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does ACHC compare to other Healthcare stocks?
ACHC ranks #105 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is ACHC overbought or oversold?
ACHC's 14-day RSI is in neutral territory - neither overbought nor oversold.
When does ACHC report earnings next?
ACHC's next earnings report is scheduled for 2026-11-04 (post-market), per the published earnings calendar.
Does ACHC usually beat earnings estimates?
Over its last 8 reported quarters ACHC beat the consensus estimate 6 times and missed 2 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about ACHC?
Of 14 analysts covering ACHC, 8 rate it a buy, 5 a hold and 1 a sell - buy-leaning, with a consensus price target of $33.8 (+12.7% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Healthcare
Head-to-head comparisons
ACHC vs AVAH · ACHC vs COGT · ACHC vs COR · ACHC vs CVS · ACHC vs DHR